Ferrero S, Leone Roberti Maggiore U. Sunitinib in endometriosis: from bench to bedside. J Obstet Gynaecol 2015;35:769 https://www.tandfonline.com/doi/pdf/10.3109/01443615.2015.1007342
Spontaneous uroperitoneum and preterm delivery in a patient with bladder endometriosis.
Leone Roberti Maggiore U, Remorgida V, Sala P, Vellone VG, Biscaldi E, Ferrero S. Spontaneous uroperitoneum and preterm delivery in a patient with bladder endometriosis. J Minim Invasive Gynecol 2015;22:923-4 https://www.jmig.org/article/S1553-4650(15)00076-X/fulltext
Evaluation of symptoms and methodology of the urodynamic study matter. J Minim Invasive Gynecol
Leone Roberti Maggiore U, Ferrero S, Salvatore S, Candiani M. Evaluation of symptoms and methodology of the urodynamic study matter. J Minim Invasive Gynecol 2015;22:701-2. https://www.jmig.org/article/S1553-4650(15)00179-X/fulltext
Intestinal Endometriosis: Mimicker of Inflammatory Bowel Disease? Digestion
Guadagno A, Grillo F, Vellone VG, Ferrero S, Fasoli A, Fiocca R, Mastracci L. Intestinal Endometriosis: Mimicker of Inflammatory Bowel Disease? Digestion 2015;92:14-21. https://www.karger.com/Article/Abstract/430908
Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome.
Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR. Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome. Eur Urol 2016;69:311-23. https://www.europeanurology.com/article/S0302-2838(15)00864-7/fulltext
Programmed intermittent epidural bolus versus continuous epidural infusion for pain relief during termination of pregnancy: a prospective, double-blind, randomized trial.
Leone Roberti Maggiore U, Silanos R, Carlevaro S, Gratarola A, Venturini PL, Ferrero S, Pelosi P. Programmed intermittent epidural bolus versus continuous epidural infusion for pain relief during termination of pregnancy: a prospective, double-blind, randomized trial. Int J Obstet Anesth 2016;25:37-44. https://www.obstetanesthesia.com/article/S0959-289X(15)00125-9/fulltext
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
Carbotti G, Barisione G, Airoldi I, Mezzanzanica D, Bagnoli M, Ferrero S, Petretto A, Fabbi M, Ferrini S. IL-27 induces the expression of IDO and PD-L1 in human cancer cells. Oncotarget 2015;6:43267-80. http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=6530&pubmed-linkout=1
Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study
Ferrero S, Racca A, Tafi E, Alessandri F, Venturini PL, Leone Roberti Maggiore U. Ulipristal Acetate Before High Complexity Hysteroscopic Myomectomy: A Retrospective Comparative Study. J Minim Invasive Gynecol 2016;23:390-5. https://www.jmig.org/article/S1553-4650(15)01705-7/fulltext
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas.
Bergamini A, Leone Roberti Maggiore U, Ferrero S, Rabaiotti E, Viganò R, Petrone M, De Marzi P, Salvatore S, Candiani M, Mangili G. Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. Expert Opion Investig Drugs 2015;24:345-362. https://www.tandfonline.com/doi/abs/10.1517/13543784.2015.999154?journalCode=ieid20